199 related articles for article (PubMed ID: 3937514)
1. Monitoring myeloma: light chain isotype suppression. A new parameter.
Wearne A; Joshua DE; Kronenberg H
Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
3. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
Hagner G
Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
[TBL] [Abstract][Full Text] [Related]
6. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
Wearne A; Joshua DE; Kronenberg H
Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
[TBL] [Abstract][Full Text] [Related]
7. [IgM myeloma].
Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
[No Abstract] [Full Text] [Related]
8. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
Bernat S; Gozalbo T; García-Boyero R; Guinot M
Sangre (Barc); 1998 Feb; 43(1):96-7. PubMed ID: 9577192
[No Abstract] [Full Text] [Related]
9. [Long-term fever and light-chain myeloma].
Gripenberg M
Duodecim; 1995; 111(4):345-7. PubMed ID: 8654302
[No Abstract] [Full Text] [Related]
10. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic plasmapheresis in patients with multiple myeloma].
Mendek-Czajkowska E; Kraj M; Pogłód R; Rostkowska J; Maj S; Sabliński J
Acta Haematol Pol; 1991; 22(1):31-41. PubMed ID: 1823964
[TBL] [Abstract][Full Text] [Related]
12. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
King MA; Vivianwells J
Clin Exp Immunol; 1981 Sep; 45(3):544-51. PubMed ID: 6175454
[TBL] [Abstract][Full Text] [Related]
13. Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies.
Büchi G; Girotto M; Veglio M; Clerico M; Gario S; Termine G; Autino R
Haematologica; 1990; 75(2):132-6. PubMed ID: 2113507
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
15. [Light chain myeloma or the pitfalls of myeloma diagnosis].
Zufferey P; Pugin P; Regamey C
Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
[TBL] [Abstract][Full Text] [Related]
16. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
[No Abstract] [Full Text] [Related]
17. An immunologic approach for the detection of tumor cells in the peripheral blood of patients with malignant lymphoma; implications for the diagnosis of minimal disease.
Ligler FS; Vitetta ES; Smith RG; Himes JB; Uhr JW; Frenkel EP; Kettman JR
J Immunol; 1979 Sep; 123(3):1123-6. PubMed ID: 112185
[TBL] [Abstract][Full Text] [Related]
18. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal IgA serum protein having a poor precipitation reaction to anti-lambda chain antiserum in the patient with multiple myeloma].
Sato K; Michibayashi T
Rinsho Byori; 1985 Dec; 33(12):1425-9. PubMed ID: 3938490
[No Abstract] [Full Text] [Related]
20. 'Light-chain escape-multiple myeloma'-an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring.
Kühnemund A; Liebisch P; Bauchmüller K; zur Hausen A; Veelken H; Wäsch R; Engelhardt M
J Cancer Res Clin Oncol; 2009 Mar; 135(3):477-84. PubMed ID: 18802723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
